SarCode draws in $7M for inflammation drugs

October 22, 2007 | David P. Hamilton | Comments | |

See our story on this San Francisco biotech in today’s daily briefing at VentureBeat Life Sciences.

Next Story: EditGrid syncs with Excel, useful for serious number-crunchers
Previous Story: Auctomatic launches better tools for eBay powersellers

Bookmark and Share

Photo of David P. Hamilton

About the Author, David P. Hamilton

David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.